Martin B Rosenberg

US Patent:

7173110, Feb 6, 2007

Filed:

Oct 31, 2005

Appl. No.:

11/264684

Inventors:

Martin J. Rosenberg - Brooklyn NY, US

Assignee:

New York University - New York NY

International Classification:

A61K 38/04
A61K 38/12

US Classification:

530328, 530317

Abstract:

Disclosed herein are isolated, purified peptides, biologically active fragments and analogs of the peptides having anti-tumor activity in mammals, pharmaceutical formulations comprising the peptides, fragments and analogs and methods of treating mammals suffering from tumors using such materials.

US Patent:

7691964, Apr 6, 2010

Filed:

Dec 22, 2006

Appl. No.:

11/615723

Inventors:

Martin Jay Rosenberg - Brooklyn NY, US

Assignee:

New York University - New York NY

International Classification:

A61K 38/12
A61K 38/00
A61K 51/00

US Classification:

530317, 514 2, 424 169

Abstract:

Disclosed herein are isolated, purified peptides, biologically active fragments and analogs of the peptides having anti-tumor activity in mammals, pharmaceutical formulations comprising the peptides, fragments and analogs and methods of treating mammals suffering from tumors using such materials.

US Patent:

8003598, Aug 23, 2011

Filed:

Dec 28, 2009

Appl. No.:

12/647899

Inventors:

Martin Jay Rosenberg - Brooklyn NY, US

Assignee:

New York University - New York NY

International Classification:

A61K 38/00
A61K 51/00

US Classification:

514 11, 530317, 424 169

Abstract:

Disclosed herein are isolated, purified peptides, biologically active fragments and analogs of the peptides having anti-tumor activity in mammals, pharmaceutical formulations comprising the peptides, fragments and analogs and methods of treating mammals suffering from tumors using such materials.

US Patent:

20050124531, Jun 9, 2005

Filed:

Feb 24, 2003

Appl. No.:

10/505715

Inventors:

George Lipkin - New York NY, US
Martin Rosenberg - Brooklyn NY, US

Assignee:

New York University - New YorK NY

International Classification:

A61K038/18
A61K031/7072
A61K031/704
A61K031/337

US Classification:

514002000, 514027000, 514049000, 514034000, 514449000

Abstract:

The present invention is directed to a method for treating a patient suffering from inappropriate or excessive angio-genic activity comprising on administering to a patient in need of such treatment an amount of Contact Inhibitory Factor effective to treat said disease. Also disclosed herein are methods for preventing a cancer cell from metastasizing comprising administering to a patient in need of such treatment Contact Inhibitory Factor and a chemtherapeutic or immunotherapeutic agent. Also disclosed are pharmaceutical formulations for use in the methods.

US Patent:

43070825, Dec 22, 1981

Filed:

Jul 10, 1979

Appl. No.:

6/056393

Inventors:

Martin J. Rosenberg - Brooklyn NY

Assignee:

New York University - New York NY

International Classification:

A61K 3500
C12P 100

US Classification:

424115

Abstract:

Described herein is a method for the extraction of an active biochemical factor that restores contact inhibition of growth to malignant cell types of different mammalian species.

US Patent:

45307849, Jul 23, 1985

Filed:

Aug 19, 1983

Appl. No.:

6/524917

Inventors:

Martin J. Rosenberg - Brooklyn NY

Assignee:

New York University - New York NY

International Classification:

A61K 3500

US Classification:

260112R

Abstract:

A method for extracting large quantities of an active biological factor that restores contact inhibition of growth to malignant cell types of different mammalian species.